Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan M Gascoyne

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|September 29, 2016
The significance of FOXP1 in diffuse large B-cell lymphomaDuncan M Gascoyne, Alison H Banham
Oncogene|March 17, 2004
The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1Duncan M Gascoyne, G Ruth Thomas, David S Latchman
The Journal of Biological Chemistry|March 15, 2003
Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xLDuncan M Gascoyne, Robert M Kypta, Maria d M Vivanco
Trends in Immunology|November 15, 2011
E4BP4: an unexpected player in the immune responseVictoria Male, Ilaria Nisoli, Duncan M Gascoyne, et al.
Cell Cycle (Georgetown, Tex.)|May 8, 2003
Loss of mitotic spindle checkpoint activity predisposes to chromosomal instability at early stages of fibrosarcoma developmentDuncan M Gascoyne, Mary L Hixon, Antonio Gualberto, et al.
Endocrinology|December 22, 2016
Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin DDuncan M Gascoyne, Linden Lyne, Hayley Spearman, et al.
Cancer Research|May 13, 2010
AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemiaJenny Dunne, Duncan M Gascoyne, T Andrew Lister, et al.
Endocrine Oncology (Bristol, England)|March 26, 2026
Vitamin D receptor expression in germinal centre type diffuse large B-cell lymphoma cells is associated with vitamin D insensitivityElizabeth J Soilleux, Amanda Anderson, Emma Roberts, et al.
Frontiers in Oncology|April 21, 2020
CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma ModelSuet Ling Felce, Amanda P Anderson, Shaun Maguire, et al.
Plos One|June 3, 2015
The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21WAF1/CIP1 in 143B Osteosarcoma Cell Growth ArrestDuncan M Gascoyne, Hayley Spearman, Linden Lyne, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|September 29, 2016
The significance of FOXP1 in diffuse large B-cell lymphomaDuncan M Gascoyne, Alison H Banham
Oncogene|March 17, 2004
The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1Duncan M Gascoyne, G Ruth Thomas, David S Latchman
The Journal of Biological Chemistry|March 15, 2003
Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xLDuncan M Gascoyne, Robert M Kypta, Maria d M Vivanco
Trends in Immunology|November 15, 2011
E4BP4: an unexpected player in the immune responseVictoria Male, Ilaria Nisoli, Duncan M Gascoyne, et al.
Cell Cycle (Georgetown, Tex.)|May 8, 2003
Loss of mitotic spindle checkpoint activity predisposes to chromosomal instability at early stages of fibrosarcoma developmentDuncan M Gascoyne, Mary L Hixon, Antonio Gualberto, et al.
Endocrinology|December 22, 2016
Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin DDuncan M Gascoyne, Linden Lyne, Hayley Spearman, et al.
Cancer Research|May 13, 2010
AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemiaJenny Dunne, Duncan M Gascoyne, T Andrew Lister, et al.
Endocrine Oncology (Bristol, England)|March 26, 2026
Vitamin D receptor expression in germinal centre type diffuse large B-cell lymphoma cells is associated with vitamin D insensitivityElizabeth J Soilleux, Amanda Anderson, Emma Roberts, et al.
Frontiers in Oncology|April 21, 2020
CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma ModelSuet Ling Felce, Amanda P Anderson, Shaun Maguire, et al.
Plos One|June 3, 2015
The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21WAF1/CIP1 in 143B Osteosarcoma Cell Growth ArrestDuncan M Gascoyne, Hayley Spearman, Linden Lyne, et al.
Pageof 2